Found 482 results in Expert Content

Read this case study to learn about how Catalent deployed its integrated OneXpress® Solution to expedite the transfer of a partner program to one of its late-stage manufacturing sites while optimizing the utilization of a limited supply of API.

A clinical-stage biotech focused on neurology faced challenges with a lipophilic, oxidation-sensitive molecule limited by solubility, stability, and scalability.

Vinorelbine, a chemotherapy agent traditionally given by IV infusion, was reformulated into the first approved oral softgel capsule through a collaboration between Pierre Fabre and Catalent.

Summary: Late-stage scaling of spray drying for inhaled formulations can result in avoidable delays, post-approval issues, and cost overruns.

Bringing complex oral drugs to the clinic requires overcoming significant solubility, permeability, and bioavailability challenges.

Summary: Pharmaceutical innovators face growing pressure to overcome solubility, permeability, and bioavailability challenges, especially for complex, poorly soluble molecules.

Summary: Early clinical trials are becoming more complex as sponsors face rising regulatory requirements and the challenges of developing advanced drug candidates.

Summary:​ The pharmaceutical industry faces mounting pressure to deliver consistent, high-quality products whilst managing escalating costs and regulatory demands.

Summary: Stick packs are valued for their compact size, ease of use, and portability, offering unique advantages for improving patient adherence and treatment experiences.

Early-phase trials are often delayed by rigid manufacturing models, fixed-dose formats, and limited API availability.